Men and women ages 18 years or older with chronic spontaneous uritcaria may qualify to participate. Hives must be present on the individual for at least 6 weeks prior to the start of the study, with a diagnosis of the disease for at least 6 months prior. A history (within 6 months) of inadequate response to treatment with anti-histamines, is also required.
Participants will receive investigational oral medication (active study drug) or placebo during the treatment period. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.
Study participation will last about 16 weeks and involve about 7 visits to the study centre.
Email Tina Craig, Clinical Research Coordinator at DermEffects to register.